Target Name: Liprin-beta-1-like
NCBI ID: G729222
Review Report on Liprin-beta-1-like Target / Biomarker Content of Review Report on Liprin-beta-1-like Target / Biomarker
Liprin-beta-1-like
Other Name(s): LOC729222

LOC729222: Potential Drug Target Or Biomarker for Heart Disease, Neurodegenerative Diseases and Cancer

Liprin-beta-1-like (LOC729222) is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a member of the Liprin family, which is known for its role in intracellular signaling.

LOC729222 has been shown to play a role in the regulation of cellular processes that are important for brain function, such as the formation and maintenance of new blood vessels, and the regulation of ion channels that are involved in the transmission of electrical signals in the brain. It is also involved in the regulation of cellular processes that are important for heart function, such as the contraction and relaxation of heart muscle.

Recent studies have suggested that LOC729222 may be a drug target or biomarker for a variety of diseases, including heart disease, neurodegenerative diseases, and cancer.

One potential mechanism by which LOC729222 may be involved in the development and progression of heart disease is by contributing to the regulation of the formation and function of blood vessels. Studies have shown that LOC729222 is involved in the regulation of the expression of genes that are involved in the formation and maintenance of new blood vessels, as well as the regulation of the formation of blood clots.

Additionally, LOC729222 has been shown to play a role in the regulation of ion channels that are involved in the transmission of electrical signals in the brain. This may be relevant to the development of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, which are characterized by the progressive loss of brain cells and the disruption of normal electrical signals.

Another potential mechanism by which LOC729222 may be involved in the development and progression of cancer is by contributing to the regulation of cellular processes that are important for cell growth and division. Studies have shown that LOC729222 is involved in the regulation of the expression of genes that are involved in cell growth and division, as well as the regulation of the formation of new blood vessels that may contribute to the development of cancer.

In conclusion, LOC729222 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular processes that are important for brain function, heart function, and cancer. Its potential as a drug target or biomarker makes it an attractive target for research into a variety of diseases. Further studies are needed to fully understand the role of LOC729222 in these processes and to determine its potential as a therapeutic agent.

Protein Name: Liprin-beta-1-like

The "Liprin-beta-1-like Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Liprin-beta-1-like comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LIPT1 | LIPT2 | LIPT2-AS1 | LITAF | Liver Bile Transporters (LBAT) | LIX1 | LIX1-AS1 | LIX1L | LKAAEAR1 | LKB1-LIP1-SMAD4 complex | LL22NC03-63E9.3 | LLCFC1 | LLGL1 | LLGL2 | LLPH | LMAN1 | LMAN1L | LMAN2 | LMAN2L | LMBR1 | LMBR1L | LMBRD1 | LMBRD2 | LMCD1 | LMCD1-AS1 | LMF1 | LMF2 | LMLN | LMNA | LMNB1 | LMNB2 | LMNTD1 | LMNTD2 | LMNTD2-AS1 | LMO1 | LMO2 | LMO3 | LMO4 | LMO7 | LMO7-AS1 | LMO7DN | LMOD1 | LMOD2 | LMOD3 | LMTK2 | LMTK3 | LMX1A | LMX1B | LMX1B-DT | LNC-LBCS | LNCAROD | LNCARSR | LNCATV | LNCNEF | LNCOC1 | LNCOG | LNCPRESS1 | LNCRI | LNCRNA-ATB | LNCRNA-IUR | LNCTAM34A | LNP1 | LNPEP | LNPK | LNX1 | LNX1-AS1 | LNX2 | LOC100127946 | LOC100127955 | LOC100128002 | LOC100128028 | LOC100128050 | LOC100128059 | LOC100128079 | LOC100128093 | LOC100128164 | LOC100128242 | LOC100128288 | LOC100128317 | LOC100128361 | LOC100128398 | LOC100128494 | LOC100128593 | LOC100128770 | LOC100128966 | LOC100128988 | LOC100129034 | LOC100129098 | LOC100129148 | LOC100129175 | LOC100129203 | LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000